Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

0RC6

Pharma Mar (0RC6)

Pharma Mar Sa
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0RC6
DateHeureSourceTitreSymboleSociété
11/01/202215h13PR Newswire (US)Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsLSE:0RC6Pharma Mar Sa
22/12/202111h17PR Newswire (US)PharmaMar signs a new licensing and commercialization agreement with Eczacibasi for lurbinectedin in TurkeyLSE:0RC6Pharma Mar Sa
13/12/202114h39PR Newswire (US)PharmaMar and Jazz Pharmaceuticals announce initiation of confirmatory phase III clinical trial of Zepzelca® (lurbinectedin) for the treatment of patients with relapsed Small Cell Lung CancerLSE:0RC6Pharma Mar Sa
11/11/202113h39PR Newswire (US)PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanLSE:0RC6Pharma Mar Sa
28/04/202012h39PR Newswire (US)PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitid...LSE:0RC6Pharma Mar Sa
 Showing the most relevant articles for your search:LSE:0RC6